Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Feb 16, 2018 2:43pm
273 Views
Post# 27574213

RE:RE:RE:RE:RE:It's Friday shorties ! better cover before the weekend,

RE:RE:RE:RE:RE:It's Friday shorties ! better cover before the weekend,you are absolutely right.... thats what they said before they knew what options were possible.

As has been discussed here,  they have been presented the possiblity of doing an ADR  ( Deposit Receipt )  whereby the Nasdaq ADR unit would defacto represent 10 or 15 TSX shares.... and there is no Reverse split.   

I will repeat.  If you have a syndicate with names like Goldman Sachs, JP Morgan or Morgan Stanley leading a deal with this value proposition properly marketed.... the value gap closes....  and goes exponential when they do a $1B   IPF deal with Boehringer on the back of the strength of raising $150-$200mm USD in an IPO.        dare to dream.... cuz I think thats whats coming here... and the shorts know it
Bullboard Posts